Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients

(2020) Sakthivel Muniyan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

(2019) Paul F. Pinsky et al.   CANCER

External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort

(2019) Derya Tilki et al.   EUROPEAN UROLOGY

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

(2019) Kim N. Chi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

(2019) Alex P. Hoyle et al.   EUROPEAN UROLOGY

Metastatic Prostate Cancer

(2018) Oliver Sartor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

(2018) Satoshi Tamada et al.   Oncotarget

The Diagnosis and Treatment of Prostate Cancer

(2017) Mark S. Litwin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

(2017) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study

(2017) Xue Qin Yu et al.   PLoS One

Prostate cancer

(2016) Gerhardt Attard et al.   LANCET

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

(2016) Freddie C. Hamdy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

(2015) Malcolm D. Mason et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

(2015) Howard I. Scher et al.   PLoS One

Prostate-Specific Antigen Screening in Prostate Cancer: Perspectives on the Evidence

(2014) T. J. Wilt et al.   JNCI-Journal of the National Cancer Institute

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

(2010) Michel Bolla et al.   LANCET ONCOLOGY

Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group

(2007) James A. Eastham et al.   EUROPEAN UROLOGY